Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease.

Literature DB >> 21292684

Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease.

Michael Camilleri¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Biomarkers

Year: 2011 PMID： 21292684 PMCID： PMC3183468 DOI： 10.1136/gut.2010.234583

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

43 in total

1. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study.

Authors: Smita L S Halder; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; L Joseph Melton; Nicholas J Talley
Journal: Gastroenterology Date: 2007-06-20 Impact factor: 22.682

Review 2. The geoepidemiology of autoimmune intestinal diseases.

Authors: Ian Logan; Christopher L Bowlus
Journal: Autoimmun Rev Date: 2009-11-10 Impact factor: 9.754

3. Cholestyramine treatment of diarrhea associated with ileal resection.

Authors: A F Hofmann; J R Poley
Journal: N Engl J Med Date: 1969-08-21 Impact factor: 91.245

4. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.

Authors: N Manabe; B S Wong; M Camilleri; D Burton; S McKinzie; A R Zinsmeister
Journal: Neurogastroenterol Motil Date: 2009-12-21 Impact factor: 3.598

5. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Authors: Magnus Simrén; Jenny Axelsson; Rolf Gillberg; Hasse Abrahamsson; Jan Svedlund; Einar S Björnsson
Journal: Am J Gastroenterol Date: 2002-02 Impact factor: 10.864

6. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre.

Authors: R Sadik; P-O Stotzer; M Simrén; H Abrahamsson
Journal: Neurogastroenterol Motil Date: 2007-11-05 Impact factor: 3.598

7. Idiopathic pancreatitis associated with inflammatory bowel disease.

Authors: J A Seyrig; R Jian; R Modigliani; D Golfain; C Florent; B Messing; A Bitoun
Journal: Dig Dis Sci Date: 1985-12 Impact factor: 3.199

8. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.

Authors: Anastassios C Manolakis; Andreas N Kapsoritakis; Panagiotis Georgoulias; Chara Tzavara; Varvara Valotassiou; Anastasia Kapsoritaki; Spyros P Potamianos
Journal: BMC Gastroenterol Date: 2010-10-14 Impact factor: 3.067

9. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.

Authors: M Camilleri; A Nadeau; W J Tremaine; J Lamsam; D Burton; S Odunsi; S Sweetser; R Singh
Journal: Neurogastroenterol Motil Date: 2009-03-13 Impact factor: 3.598

Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease.

1. Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study.

Review 2. The geoepidemiology of autoimmune intestinal diseases.

3. Cholestyramine treatment of diarrhea associated with ileal resection.

4. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.

5. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

6. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre.

7. Idiopathic pancreatitis associated with inflammatory bowel disease.

8. Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.

9. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.

Review 10. Use and abuse of hydrogen breath tests.

1. Targeting mucosal healing in Crohn's disease.

2. Irritable bowel syndrome: how useful is the term and the 'diagnosis'?

3. Pain management in patients with inflammatory bowel disease: insights for the clinician.

Review 4. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.

Review 5. Refractory inflammatory bowel disease-could it be an irritable bowel?

6. Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease.

Review 7. Enhancing High Value Care in Gastroenterology Practice.